The Profit of Aging: Minnesota Weighs Strict Oversight of Private Equity in Eldercare

ST. PAUL, MN — In the quiet corridors of Minnesota’s nursing homes and assisted living facilities, a high-stakes legislative battle is unfolding over the soul of eldercare. At the heart of the debate is a fundamental question: Can the aggressive, short-term profit motives of private equity coexist with the long-term, delicate needs of an aging population?

Representative Liz Reyer (DFL-Eagan) is an unlikely crusader against corporate influence. Before her tenure in the Minnesota House, she spent years in the private sector, conducting market research for giants like Blue Cross and Blue Shield of Minnesota. Her background has instilled in her a pragmatic view of the intersection between business and health care; she is quick to clarify that she does not support a blanket ban on private equity.

However, Reyer is now the chief author of a provocative new bill that seeks to pull back the curtain on the opaque ownership structures currently dominating the eldercare industry. Alongside a coalition of DFLers and consumer advocates, Reyer is pushing for a regulatory framework that would subject private equity firms to unprecedented levels of scrutiny before they can acquire facilities responsible for the state’s most vulnerable citizens.

Main Facts: The Drive for Transparency and Accountability

The proposed legislation, HF 2771 (with a Senate companion, SF 2972), represents a significant shift in how Minnesota oversees its 339 skilled nursing facilities and more than 2,350 assisted living homes. Currently, the Minnesota Department of Health (MDH) requires owners to disclose whether they operate as a nonprofit, a for-profit business, or a public entity. However, the specific corporate architecture—including the involvement of private equity firms—is often buried under layers of shell companies and holding groups.

The bill introduces several rigorous requirements for private equity firms seeking to enter the Minnesota market:

1. Advance Notification: Facility operators must notify the state 120 days before a sale to a private equity firm.
2. Detailed Disclosure: Purchasing firms must provide a "bevy of disclosure statements," including a complete and granular map of their corporate structure.
3. Vetting History: Regulators would have the power to block transactions if the private equity operator has faced adverse legal judgments within the last 10 years.
4. Capital Mandates: New owners would be legally required to invest sufficient capital to maintain infrastructure and staffing levels, a direct counter-measure to "asset stripping."

The bill’s supporters view these measures as a necessary defense against a "modern-day plague." Senator Erin Maye Quade (DFL-Apple Valley) has been among the most vocal critics, arguing during a recent Senate Human Services Committee hearing that private equity’s "sole purpose is to squeeze every single cent out of the function of whatever business they’ve glommed onto to ruin."

Chronology: The Rise of the "Investment Model" in Healthcare

To understand the urgency of the current legislative push, one must look back to the mid-2010s. According to Yashaswini Singh, a prominent health care economist at Brown University, private equity emerged as a dominant force in health care investment around 2015.

Unlike traditional owner-operators who may view a nursing home as a multi-generational asset, private equity firms typically operate on a "fixed-date" return model. Investors—which often include pension funds and institutional stock managers—expect a significant return on their investment within a window of ten years or less.

This truncated timeline has created a systemic shift in how facilities are managed:

• 2015–2020: Rapid acquisition of independent nursing homes by private equity groups accelerated nationwide, driven by the steady revenue streams provided by Medicare and Medicaid.
• 2021–2023: States like California, Massachusetts, and Oregon began passing transparency laws after reports surfaced of declining care quality in PE-owned facilities.
• 2024: National advocacy groups, such as Consumer Voice, released comprehensive reports linking private equity ownership to higher staff turnover and increased resident mortality.
• Present Day: The Minnesota Legislature is now grappling with HF 2771, which was recently "laid over" in committee—a procedural move that keeps the bill alive for potential inclusion in a year-end omnibus package.

Supporting Data: The High Cost of Cost-Cutting

The push for regulation is backed by a growing body of academic and federal data suggesting that the private equity business model is fundamentally at odds with high-quality clinical outcomes.

The Staffing Crisis

Data from Consumer Voice indicates that staff turnover—the percentage of employees who leave within a single year—is significantly higher in facilities owned by private equity. For instance, in Tennessee, facilities managed by the firm Portopiccolo saw turnover rates as high as 61%. High turnover is widely recognized by health experts as a primary driver of medical errors, bedsores, and resident depression.

Mortality and Clinical Risks

Atul Gupta, a professor at Wharton Health Care Management, led a landmark study that found residents in private equity-owned nursing homes have a higher mortality rate than those in non-PE-owned for-profit facilities. Gupta’s research suggests that these firms often "cherry-pick" patients with lower health risks to minimize costs while simultaneously reducing the number of frontline caregivers.

Financial "Self-Dealing"

One of the most complex issues identified by researchers is "financial self-dealing." In this scenario, a private equity firm buys a nursing home, sells the underlying real estate to a separate entity it also owns, and then forces the nursing home to lease the building back at exorbitant rates. This practice drains the facility’s operating budget, leaving less money for food, medicine, and nursing staff, while enriching the parent company through real estate dividends.

In Minnesota, the true extent of this practice remains unknown. As Kelly Asche, a researcher at the Center for Rural Policy and Development, noted, "Private equity ownership is not identifiable from standard licensing types."

Official Responses: A Divided Statehouse

The legislative debate has drawn a sharp line between those who prioritize consumer protection and those who fear the economic consequences of over-regulation.

The Proponents

Rep. Liz Reyer maintains that the bill is about basic transparency. "We are thrust into dealings with complex and impersonal business identities," she said. "We might not even know who our provider is."

Sen. Alice Mann (DFL-Edina), the Senate sponsor, argues that the state has a moral obligation to ensure that public tax dollars (via Medicaid) are being used for care rather than being diverted to satisfy the internal rate of return for distant investors.

The Opposition

Industry representatives and Republican lawmakers argue that the bill could exacerbate an already dire situation for Minnesota’s seniors. The Long Term Care Imperative, a powerful lobbying partnership, warned that the "paperwork and regulation" would create "more burdens for senior living communities," ultimately harming affordability.

Rep. Natalie Zeleznikar (R-Fredenberg Township), a former nursing home executive, highlighted the fragility of the industry. With nursing facilities already closing—particularly in rural areas—Zeleznikar argued that "there are not a lot of people waiting to buy nursing homes." She expressed concern that by demonizing private investment, the state might scare away the very capital needed to keep doors open and beds available.

Rep. Jeff Backer (R-Browns Valley) took a more middle-ground approach. While he agreed with the bill’s goals regarding transparency, he questioned whether the specific requirements for capital investment and the 10-year lookback on legal judgments might be too punitive, potentially "scaring away" responsible investors.

Implications: The Future of Eldercare in Minnesota

As the 2024-2025 legislative cycle continues, the fate of HF 2771 will serve as a bellwether for Minnesota’s regulatory appetite. If passed, the bill would make Minnesota one of the most transparent states in the nation regarding healthcare ownership.

The implications are threefold:

1. Market Realignment: Stricter regulations may lead some private equity firms to exit the Minnesota market, potentially leaving a vacuum that nonprofits or smaller regional operators may struggle to fill. Conversely, it could stabilize the market by ensuring only long-term investors remain.
2. The "Omnibus" Strategy: Because the bills were "laid over," they are likely to be folded into a massive, "catch-all" omnibus bill at the end of the session. This is a common legislative tactic in St. Paul, but it often means that significant policy shifts occur with less individual debate than a standalone bill would receive.
3. Rural Healthcare Deserts: For rural Minnesota, where nursing home closures are already a crisis, the impact of this bill will be felt most acutely. If the regulations succeed in improving care without stifling investment, they could provide a blueprint for rural healthcare stability. If they fail, they may accelerate the trend of "healthcare deserts" in the state’s outstate regions.

For now, the conversation remains open. As Senate Human Services Committee Chair John Hoffman (DFL-Champlin) concluded during the recent hearing, the state is not yet ready to vote, but the urgency of the issue ensures it will remain at the forefront of the legislative agenda. "We’re just going to lay over and keep the conversation going," Hoffman said—a signal that while the bill is paused, the scrutiny of private equity in Minnesota is only just beginning.